China Biologic Products is a biotechnology business based in the US. China Biologic Products shares (CBPO) are listed on the NASDAQ and all prices are listed in US Dollars.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – CBPO.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy China Biologic Products stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
China Biologic Products stock price (NASDAQ: CBPO)
Use our graph to track the performance of CBPO stocks over time.
Is it a good time to buy China Biologic Products stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is China Biologic Products stock undervalued or overvalued?
Valuing China Biologic Products stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of China Biologic Products's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
China Biologic Products's P/E ratio
China Biologic Products's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, China Biologic Products shares trade at around 31x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
China Biologic Products's PEG ratio
China Biologic Products's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.53. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into China Biologic Products's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
China Biologic Products's EBITDA
China Biologic Products's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $222.6 million.
The EBITDA is a measure of a China Biologic Products's overall financial performance and is widely used to measure a its profitability.
China Biologic Products financials
Revenue TTM
$524.4 million
Operating margin TTM
37.26%
Gross profit TTM
$344.4 million
Return on assets TTM
5.82%
Return on equity TTM
9.25%
Profit margin
29.04%
Book value
$51.12
Market Capitalization
$4.6 billion
TTM: trailing 12 months
China Biologic Products share dividends
We're not expecting China Biologic Products to pay a dividend over the next 12 months.
China Biologic Products share price volatility
Over the last 12 months, China Biologic Products's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while China Biologic Products's is 0.4242. This would suggest that China Biologic Products's shares are less volatile than average (for this exchange).
China Biologic Products overview
China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and IVIG for original and secondary immunoglobulin deficiency, auto-immune deficiency, and immunoglobulin G secondary deficiency; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; human fibrinogen; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing Human fibrinogen for the treatment for lack of fibrinogen and increase human fibrinogen concentration; and artificial dura and spinal dura mater products for use in brain and spinal surgeries. The company sells its products directly, as well as through distributors.
Frequently asked questions
null What percentage of China Biologic Products is owned by insiders or institutions? Currently 45.077% of China Biologic Products shares are held by insiders and 51.031% by institutions.When does the fiscal year end for China Biologic Products? China Biologic Products's fiscal year ends in December.Where is China Biologic Products based? China Biologic Products's address is: Jialong International Tower, Beijing, China, 100125What is China Biologic Products's ISIN number? China Biologic Products's international securities identification number is: US16938C1062What is China Biologic Products's CUSIP number? China Biologic Products's Committee on Uniform Securities Identification Procedures number is: G21515104
A deep dive into the highlights and limitations of Robinhood.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
